美国亚特兰大消息:目前正在对6种似乎能干扰AIDS病毒复制的药物进行研究。哈佛大学医学副教授Martin Hirsch在最近当地召开的国际AIDS会议上评论了AIDS病研究的进展。他说,HTL A-Ⅲ/LAV的复制过程,提供了许多可能的部位使药物能对此病毒产生作用。此病毒首先附在与T淋巴细胞上的T辅助抗原有关的特异受体上。然后病毒进入细胞,被解码,逆转录酶作用于RNA——开始制造单互补链DNA,以后是DNA-RNA过度 Atlanta, United States: Six drugs that seem to disrupt AIDS virus replication are currently under study. Martin Hirsch, an associate professor of medicine at Harvard University, commented on the progress of AIDS research at a recent local AIDS conference. He said that the replication process of HTL A-III / LAV provides many possible sites for the drug to exert its effects on this virus. This virus is first attached to a specific receptor associated with the T helper antigen on T lymphocytes. The virus then enters the cell, is decoded, and reverse transcriptase acts on the RNA - starting to make single-stranded DNA, which is followed by excessive DNA-RNA